Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
Register now or login to post to this thread.

Oxford Instruments (OXIG)     

dreamcatcher - 04 Sep 2012 18:59

http://www.oxford-instruments.com/Pages/home.aspx


Oxford Instruments is a leading provider of high technology tools and systems for research and industry. We design and manufacture equipment that can fabricate, analyse and manipulate matter at the atomic and molecular level.

Oxford Instruments has discrete business groups operating in three sectors. This means we can focus our expertise, our technologies and our innovation on offering our customers high quality products and service that meet their stringent requirements.

Chart.aspx?Provider=EODIntra&Code=OXIG&SChart.aspx?Provider=EODIntra&Code=OXIG&S





Financial Calendar


Half Year/Interim Results Announcement

Tuesday November 13th 2012 : 9.30am The London Stock Exchange

Annual General Meeting:

Tuesday 11th September 2012 : 2.30pm

Oxford Instruments plc, Tubney Woods, Abingdon, Oxon OX13 4QX

26 September 2012 Ordinary shares quoted ex-dividend
28 September 2012 Record date for final dividend
30 September 2012 DRIP date
25 October 2012 Payment of final dividend
March 2013 Ordinary shares quoted ex-dividend
Dividend reinvestment (DRIP) last date for election
Record date for interim dividend
31 March 2013 Financial Year End

dreamcatcher - 12 Jul 2013 19:42 - 51 of 121

12 Jul N+1 Singer 1,390.00 Hold

dreamcatcher - 12 Jul 2013 21:13 - 52 of 121

Oxford Instruments reports slow start to the year

Fri, 12 July 2013



Chg %: 9.60%

Date: 16:41


Oxford Instruments, which provides technology for research, had a slow start to the year but sales have picked up, according to a trading update for April 1st to date.

The company said performance in the first two months of the year was down in comparison to a strong prior year. However, sales and profits improved in the third month of the quarter, ahead of the same period last year.

Average monthly order intake in the quarter was higher than the last financial year in Asia by 18% but below in North America by 20% and in Europe by 1.0%.

“Our broad spread of geographies and technologies and our strong pipeline of new products continue to underpin the long term prospects for the group,” the company said.

“The board anticipates that Oxford Instruments will continue to make progress in line with its expectations for the remainder of the financial year and remains focused on achieving its 14 Cubed objectives.”

dreamcatcher - 15 Jul 2013 20:55 - 53 of 121

15 Jul Jefferies... 1,420.00 Hold
15 Jul JP Morgan... 1,750.00 Overweight

Stan - 23 Jul 2013 16:22 - 54 of 121

Kames Capital go below 3%

dreamcatcher - 02 Sep 2013 17:58 - 55 of 121

Oxford Instruments: Numis downgrades to add with a target price of 1600p

dreamcatcher - 10 Sep 2013 07:25 - 56 of 121


AGM Statement

RNS


RNS Number : 5749N

Oxford Instruments PLC

10 September 2013






Oxford Instruments plc

Chairman's AGM Statement 2013



Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, is holding its annual general meeting today in which the Chairman, Nigel Keen will make the following statement:



"In June 2011 we outlined our 14 Cubed objective to achieve a compound annual revenue growth rate of 14% and a return on sales of 14% by the financial year ending March 2014. It was anticipated that this objective would be achieved predominantly through organic growth and continuing internal efficiency improvements, augmented by targeted acquisitions.



The year to March 2013 was the second year of the 14 Cubed plan and we saw compound revenue growth of 15.6% over the two years with return on sales last year of 14.2%.



In the current year, average monthly orders in our Nanotechnology Tools sector are ahead of last year in Asia but are behind in North America and Europe as government agencies in these territories examine their spending on Research and Development. We believe this is particularly true in the USA where the uncertainty caused by budget sequestration has caused orders to be delayed. Asylum Technology, which we acquired in December 2012, is performing well, with results in line with expectations.



Our Industrial Products sector has seen growth in average monthly orders over the previous year in Asia and Europe as global economies begin to recover. North America is still down on the prior year but the trend is improving.



Our third party service business is performing well with the recently acquired Platinum Medical Imaging business continuing to gain traction and delivering the integration benefits.



Outlook

The growth in the order intake rate in Industrial Products and third party Service is encouraging but the slowness in R&D markets in the Western economies means that the year is likely to be more second half weighted than has been seen in recent periods. This will be aided by the continuing recovery in trading conditions in North America

Stan - 16 Sep 2013 09:15 - 57 of 121

The Capital Group Companies, Inc. go above 16% http://www.moneyam.com/action/news/showArticle?id=4667837

dreamcatcher - 18 Sep 2013 21:48 - 58 of 121

18 Sep Investec 1,515.00 Hold

Stan - 21 Oct 2013 09:17 - 59 of 121

Black Rock Inc. Go below 18% http://www.moneyam.com/action/news/showArticle?id=4690166

Stan - 11 Nov 2013 21:33 - 60 of 121

Interim's out tomorrow, wonder how much the foreign exchange rates are affecting these.

dreamcatcher - 11 Nov 2013 21:54 - 61 of 121

Stan, this was in Shares this week -The company designs and supplies some of the very high-technology tools and systems that scientists and researchers need to develop advanced applications. Its business model sees high-tech equipment sold into nanotechnology and industrial markets across the globe, and increasingly to Far East markets keen to expand their technological and scientific research base. This provides a vast and growing installed base from which after-sales parts and service revenues stem, generating highly visible and rising revenues. The company prides itself on turning smart science and innovation into commercially successful products, raising the barriers to entry for new competitors. Research spending cuts in Europe and the US have temporarily slammed the brakes on yet Oxford insists it remains on target to match its ’14 Cubed’ objectives (14% average revenue growth and return on sales, by 2014) (see The Big Debate, pages 36-37). Analysts at Numis point out: ‘Demand for Oxford’s products is being driven by the shift to smaller applications and the ability to analyse and manipulate matter at the atomic level.’ That means increasing nanotechnology research paid for with bigger and bigger budgets, in time. Numis estimates funding levels will increase between 10% and 20% a year going forward, underpinning EPS estimates it has for Oxford of 75.6p next year to March 2015, and 84.2p the year after. That implies a PE of 17.3 falling to 15.

Stan - 11 Nov 2013 22:18 - 62 of 121

Thanks for that DC, we will know tomorrow.

dreamcatcher - 12 Nov 2013 17:16 - 64 of 121

Oxford Instruments notes Andor response to bid 12 November 2013 | 15:19pm StockMarketWire.com - Oxford Instruments [LON:OXIG] notes the recent announcement made by Andor Technology plc [LON:AND]. Oxford Instruments has a high regard for the Andor business and its employees and is grateful for the Board of Andor's constructive engagement in the ongoing discussions. Oxford Instruments is developing its business in the Nano-Bio field and believes that the acquisition of Andor has significant industrial and commercial logic. Having substantially completed its due diligence, Oxford Instruments believes that the indicative offer of 500p per share in cash represents an attractive proposal to Andor shareholders. Oxford Instruments looks forward to continuing discussions with the Board of Andor and working with it towards a recommended transaction. At 3:19pm: [LON:OXIG] Oxford Instruments PLC share price was +164p at 1391p Story provided by StockMarketWire.com - See more at: http://www.stockmarketwire.com/article/4704413/Oxford-Instruments-notes-Andor-response-to-bid.html#sthash.r0GAiao3.dpuf



12 Nov N+1 Singer 1,425.00 Hold

Stan - 12 Nov 2013 17:36 - 65 of 121

Up nearly 9% on the day.

dreamcatcher - 12 Nov 2013 17:39 - 66 of 121

? 16.14% on the day. :-))

Stan - 12 Nov 2013 18:27 - 67 of 121

Really DC? Only just under 9% on my precent source, Which is not on here unfortunately at the moment.

dreamcatcher - 12 Nov 2013 18:37 - 68 of 121

Have you made 9% on the day Stan, is that what you mean. :-))


Current Share Price Information from OXIG company site.


Current (p) 1425.00

Change (p) 198.00

Change (%) 16.14

Best Bid (p) 1266.00

Best Offer (p) 1980.00

Day Volume 592,770



Stan - 12 Nov 2013 21:21 - 69 of 121

Chance a be a fine thing DC -): Just looked on their site and yes your right, wow what a rise! Can't remember are you in these at present?

dreamcatcher - 12 Nov 2013 21:26 - 70 of 121

No Stan :-((
Register now or login to post to this thread.